Comerica Bank’s BridgeBio Pharma BBIO Stock Holding History

Comerica Bank’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.01M	Buy	52,480 +5,084	+11%	+$334K	0.02%	736
2025 Q3	$2.46M	Buy	47,396 +12,367	+35%	+$603K	0.01%	1058
2025 Q2	$1.51M	Sell	35,029 -48,662	-58%	-$1.77M	0.01%	1290
2025 Q1	$2.89M	Sell	83,691 -22,425	-21%	-$756K	0.01%	921
2024 Q4	$2.91M	Buy	106,116 +60,256	+131%	+$1.56M	0.01%	965
2024 Q3	$1.17M	Buy	45,860 +33,065	+258%	+$868K	﹤0.01%	1456
2024 Q2	$324K	Sell	12,795 -25,719	-67%	-$703K	﹤0.01%	2037
2024 Q1	$1.19M	Buy	38,514 +38,277	+16,151%	+$1.3M	0.01%	1448
2023 Q4	$9.56K	Sell	237 -109	-32%	-$3.27K	﹤0.01%	3165
2023 Q3	$9.12K	Buy	+346	New	+$9.82K	﹤0.01%	3223

Other funds holding BBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Bank's BBIO Position: Q4 2025 in Review

Comerica Bank increased its BridgeBio Pharma (BBIO) stake by 11% in Q4 2025, buying an estimated $334K and bringing the position to 52,480 shares worth $4.01M. The position accounts for 0.02% of the portfolio, ranked #736.

Comerica Bank first reported a position in BBIO in Q3 2023 and has held it in 10 quarters since. 433 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

Comerica Bank held 52,480 shares of BridgeBio Pharma worth $4.01M as of Q4 2025.
Comerica Bank bought 5,084 BridgeBio Pharma shares in Q4 2025, an estimated $334K.
BridgeBio Pharma made up 0.02% of Comerica Bank's portfolio in Q4 2025, its #736 holding.
Comerica Bank first reported a position in BridgeBio Pharma in Q3 2023 and has held it in 10 quarters since.
433 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.